AZD6738 Plus Durvalumab in Biliary Tract Cancer

Clinical trial NCT04298008 · UNKNOWN

Trial details

NCT number: NCT04298008
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Bile Duct Cancer Chemotherapy Effect

Start date: 2020-06-25
Primary completion: 2024-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.